SC 13D/A | 2024-03-06 | Frazier Life Sciences VIII, L.P. | Arcutis Biotherapeutics, Inc. | 8,785,284 | 7.8% | EDGAR |
SC 13G/A | 2024-03-06 | JENNISON ASSOCIATES LLC | Arcutis Biotherapeutics, Inc. | 12,128,533 | 10.8% | EDGAR |
SC 13G/A | 2024-02-14 | PRUDENTIAL FINANCIAL INC | Arcutis Biotherapeutics, Inc. | 9,884,137 | 10.5% | EDGAR |
SC 13G/A | 2024-02-13 | SUVRETTA CAPITAL MANAGEMENT, LLC | Arcutis Biotherapeutics, Inc. | 9,534,837 | 10.0% | EDGAR |
SC 13G/A | 2024-02-13 | Polar Capital Holdings Plc | Arcutis Biotherapeutics, Inc. | 6,297,688 | 6.7% | EDGAR |
SC 13G | 2024-02-13 | VANGUARD GROUP INC | Arcutis Biotherapeutics, Inc. | 4,896,513 | 5.2% | EDGAR |
SC 13G | 2024-02-12 | MORGAN STANLEY | Arcutis Biotherapeutics, Inc. | 6,093,497 | 6.5% | EDGAR |
SC 13G | 2024-02-12 | Rubric Capital Management LP | Arcutis Biotherapeutics, Inc. | 6,644,530 | 7.0% | EDGAR |
SC 13G | 2024-02-08 | JENNISON ASSOCIATES LLC | Arcutis Biotherapeutics, Inc. | 9,066,082 | 9.6% | EDGAR |
SC 13G | 2024-01-31 | Point72 Asset Management, L.P. | Arcutis Biotherapeutics, Inc. | 4,836,116 | 5.1% | EDGAR |
SC 13G | 2024-01-29 | BlackRock Inc. | Arcutis Biotherapeutics, Inc. | 5,916,546 | 6.3% | EDGAR |
SC 13G/A | 2024-01-23 | STATE STREET CORP | Arcutis Biotherapeutics, Inc. | - | 1.6% | EDGAR |
SC 13G | 2023-11-16 | Polar Capital Holdings Plc | Arcutis Biotherapeutics, Inc. | 7,117,944 | 7.6% | EDGAR |
SC 13G/A | 2023-11-13 | FMR LLC | Arcutis Biotherapeutics, Inc. | 3,551,261 | 3.8% | EDGAR |
SC 13G | 2023-11-09 | PRUDENTIAL FINANCIAL INC | Arcutis Biotherapeutics, Inc. | 9,650,811 | 10.2% | EDGAR |
SC 13G/A | 2023-11-07 | BlackRock Inc. | Arcutis Biotherapeutics, Inc. | 3,880,402 | 4.1% | EDGAR |
SC 13G | 2023-10-30 | SUVRETTA CAPITAL MANAGEMENT, LLC | Arcutis Biotherapeutics, Inc. | 9,592,212 | 10.0% | EDGAR |
SC 13D/A | 2023-10-26 | Frazier Life Sciences VIII, L.P. | Arcutis Biotherapeutics, Inc. | 8,764,232 | 9.3% | EDGAR |
SC 13G/A | 2023-02-14 | Point72 Asset Management, L.P. | Arcutis Biotherapeutics, Inc. | 1,103,576 | 1.8% | EDGAR |
SC 13G/A | 2023-02-09 | FMR LLC | Arcutis Biotherapeutics, Inc. | 9,139,173 | 15.0% | EDGAR |